Philip J. Mease, MD, MACR - Targeting Unmet Needs in Psoriatic Arthritis: Cases in Achieving Treatment Goals With TYK2 Inhibition

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/DCN865. CME/MOC/NCPD/AAPA/IPCE credit will be available until March 19, 2027. Targeting Unmet Needs in Psoriatic Arthritis: Cases in Achieving Treatment Goals With TYK2 Inhibition In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported through an educational grant from Bristol Myers Squibb. Disclosure information is available at the beginning of the video presentation.

You can listen to Philip J. Mease, MD, MACR - Targeting Unmet Needs in Psoriatic Arthritis: Cases in Achieving Treatment Goals With TYK2 Inhibition online on Radio and Podcast. Open the player on this page to stream the available audio.

Philip J. Mease, MD, MACR - Targeting Unmet Needs in Psoriatic Arthritis: Cases in Achieving Treatment Goals With TYK2 Inhibition is an episode from PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast by PeerView, 24 West 40th Street, Suite 950, New York, NY 10018.

This episode is 00:51:14 long.

This episode was published on Mar 24, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast when more episodes are available from the podcast feed.